FoRx Therapeutics raises €10.0M Seed round
22 April 2020· Basel, Switzerland· health, oncology, biotech, small_molecule_drugs, b2b
To develop a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways.
Investors
LeadM Ventures
Also participating
Novartis Venture FundOmega FundsPfizer VenturesLSP
About FoRx Therapeutics
Stage
Series A
Headquarters
Basel, Switzerland
Founded
2019
Team Size
21–50
Sectors
healthoncologybiotechsmall_molecule_drugsb2b